Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SEEL Gross Margin

The Gross Margin of Seelos Therapeutics Inc (SEEL) is 80.95%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

SEEL Gross Margin - Historical Value
Date Value
2023-12-31 80.95%
2022-12-31 80.95%
2021-12-31 90.09%
SEEL Gross Margin - Peers Comparison